strips 19 38 Search Results


strips 19 38  (ATCC)
94
ATCC strips 19 38
Strips 19 38, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/strips 19 38/product/ATCC
Average 94 stars, based on 1 article reviews
strips 19 38 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
covid-19 ag respi-strip  (Coris Bioconcept)
90
Coris Bioconcept covid-19 ag respi-strip
Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection
Covid 19 Ag Respi Strip, supplied by Coris Bioconcept, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/covid-19 ag respi-strip/product/Coris Bioconcept
Average 90 stars, based on 1 article reviews
covid-19 ag respi-strip - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
copper adhesive tape  (RS Components)
90
RS Components copper adhesive tape
Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection
Copper Adhesive Tape, supplied by RS Components, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/copper adhesive tape/product/RS Components
Average 90 stars, based on 1 article reviews
copper adhesive tape - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
gradient ipg strip  (Bio-Rad)
96
Bio-Rad gradient ipg strip
Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection
Gradient Ipg Strip, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gradient ipg strip/product/Bio-Rad
Average 96 stars, based on 1 article reviews
gradient ipg strip - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
goat antimouse igg conjugated with fluorescein isothiocyanate (fitc)  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology goat antimouse igg conjugated with fluorescein isothiocyanate (fitc)
Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection
Goat Antimouse Igg Conjugated With Fluorescein Isothiocyanate (Fitc), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat antimouse igg conjugated with fluorescein isothiocyanate (fitc)/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
goat antimouse igg conjugated with fluorescein isothiocyanate (fitc) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
oxygen plasma  (PVA Tepla Analytical Systems GmbH)
90
PVA Tepla Analytical Systems GmbH oxygen plasma
Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection
Oxygen Plasma, supplied by PVA Tepla Analytical Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oxygen plasma/product/PVA Tepla Analytical Systems GmbH
Average 90 stars, based on 1 article reviews
oxygen plasma - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rnf138 nm 001191324 human tagged orf clone  (OriGene)
N/A
RNF138 GFP tagged Human ring finger protein 138 RNF138 transcript variant 3
   Buy from Supplier
rnf138 nm 019706 mouse tagged orf clone lentiviral particle  (OriGene)
N/A
Lenti ORF particles Rnf138 Myc DDK tagged Mouse ring finger protein 138 Rnf138 transcript variant 2 200ul 10 7 TU mL
   Buy from Supplier
rnf138 nm 001191324 human tagged orf clone lentiviral particle  (OriGene)
N/A
Lenti ORF particles RNF138 mGFP tagged Human ring finger protein 138 RNF138 transcript variant 3 200ul 10 7 TU mL
   Buy from Supplier
rnf138 nm 198128 human tagged orf clone  (OriGene)
N/A
RNF138 Myc DDK tagged Human ring finger protein 138 RNF138 transcript variant 2
   Buy from Supplier
rnf138 nm 019706 mouse tagged orf clone  (OriGene)
N/A
Rnf138 GFP tagged Mouse ring finger protein 138 Rnf138 transcript variant 2
   Buy from Supplier

Image Search Results


Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Diagnostic accuracy of point‐of‐care antigen and molecular‐based tests for the diagnosis of SARS‐CoV‐2 infection

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Diagnostic Assay, Biomarker Discovery, Infection, Sample Prep, Transmission Assay, Reverse Transcription, Polymerase Chain Reaction

Antigen tests: summary data by test brand and compliance with manufacturers' instructions for use

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Antigen tests: summary data by test brand and compliance with manufacturers' instructions for use

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Surround Optical-fiber Immunoassay

Antigen tests: summary data by symptom status, test brand and compliance with manufacturers' instructions for use

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Antigen tests: summary data by symptom status, test brand and compliance with manufacturers' instructions for use

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Surround Optical-fiber Immunoassay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet:

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Virus, Infection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet:

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Diagnostic Assay, Sampling, Comparison, Saline, Fluorescence, Control, Sequencing, Sample Prep, Surround Optical-fiber Immunoassay, Sterility, Immunochromatographic Assay, Lateral Flow Assay, Reverse Transcription, Polymerase Chain Reaction, Standard Deviation

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet:

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Extraction, Control, Negative Control, Sampling, Fluorescence, Sterility, Stripping Membranes, Biomarker Discovery, Generated, Virus, Positive Control, Surround Optical-fiber Immunoassay, Transferring, Immunofluorescence, Amplification, Ii Assay, Sample Prep, Reverse Transcription Polymerase Chain Reaction, Lateral Flow Assay, Reverse Transcription, Polymerase Chain Reaction

Data tables by test

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Data tables by test

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Surround Optical-fiber Immunoassay

<xref ref-type= Blairon 2020 " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Blairon 2020

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Biomarker Discovery, Selection

<xref ref-type= FIND 2020d (DE) " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: FIND 2020d (DE)

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Extraction, Multiplex Assay, Infection, Selection

<xref ref-type= FIND 2020e (DE) " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: FIND 2020e (DE)

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Extraction, Control, Infection, Selection

<xref ref-type= Kruger 2020(b) " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Kruger 2020(b)

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Selection

<xref ref-type= Lambert‐Niclot 2020 " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Lambert‐Niclot 2020

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Bioprocessing, Control, Selection

<xref ref-type= Mertens 2020 " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Mertens 2020

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Biomarker Discovery, Bioprocessing, Immunochromatographic Assay, Virus, Diagnostic Assay, Stripping Membranes, Selection

<xref ref-type= Scohy 2020 " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Scohy 2020

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Control, Real-time Polymerase Chain Reaction, Selection

<xref ref-type= Veyrenche 2020 " width="100%" height="100%">

Journal: The Cochrane Database of Systematic Reviews

Article Title: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

doi: 10.1002/14651858.CD013705.pub2

Figure Lengend Snippet: Veyrenche 2020

Article Snippet: For antigen test evaluations in symptomatic people, we selected three assays representing the range in observed average sensitivities: Coris Bioconcept COVID‐19 Ag Respi‐Strip (34.1% to 95% CI 29.7% to 38.8%), Abbott ‐ Panbio Covid‐19 Ag (75.1% to 95% CI 57.3% to 87.1%); and SD Biosensor ‐ STANDARD Q COVID‐19 Ag (88.1% to 95% CI 84.2% to 91.1%).

Techniques: Sampling, Selection